EGM
ALNY icon

Engineers Gate Manager’s Alnylam Pharmaceuticals ALNY Stock Holding History

Engineers Gate Manager’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.1M Buy
33,469
+967
+3% +$292K 0.13% 172
2026
Q1 		$10.8M Buy
32,502
+12,303
+61% +$4.19M 0.13% 186
2025
Q4 		$8.03M Sell
20,199
-23,650
-54% -$10.5M 0.1% 235
2025
Q3 		$20M Buy
43,849
+11,219
+34% +$4.57M 0.23% 85
2025
Q2 		$10.6M Buy
32,630
+7,238
+29% +$2M 0.13% 209
2025
Q1 		$6.86M Sell
25,392
-8,505
-25% -$2.19M 0.12% 242
2024
Q4 		$7.98M Buy
33,897
+22,034
+186% +$5.79M 0.14% 208
2024
Q3 		$3.26M Buy
11,863
+4,789
+68% +$1.25M 0.06% 429
2024
Q2 		$1.72M Sell
7,074
-17,649
-71% -$2.79M 0.04% 625
2024
Q1 		$3.69M Buy
24,723
+7,292
+42% +$1.22M 0.1% 277
2023
Q4 		$3.34M Buy
+17,431
New +$2.97M 0.1% 289
2023
Q3 		– Sell
-5,286
Closed -$1M – 1769
2023
Q2 		$1M Sell
5,286
-909
-15% -$180K 0.04% 689
2023
Q1 		$1.24M Buy
+6,195
New +$1.3M 0.05% 504
2022
Q4 		– Sell
-1,957
Closed -$392K – 1652
2022
Q3 		$392K Sell
1,957
-3,467
-64% -$661K 0.02% 958
2022
Q2 		$791K Buy
+5,424
New +$769K 0.03% 848
2022
Q1 		– Sell
-1,990
Closed -$337K – 1817
2021
Q4 		$337K Buy
1,990
+856
+75% +$159K 0.02% 1320
2021
Q3 		$214K Sell
1,134
-14,830
-93% -$2.78M 0.01% 1402
2021
Q2 		$2.71M Buy
15,964
+13,054
+449% +$1.91M 0.17% 114
2021
Q1 		$411K Buy
2,910
+420
+17% +$63.2K 0.02% 1114
2020
Q4 		$324K Buy
2,490
+1,090
+78% +$146K 0.01% 1252
2020
Q3 		$204K Sell
1,400
-2,100
-60% -$298K 0.01% 1425
2020
Q2 		$518K Buy
+3,500
New +$472K 0.03% 926
2020
Q1 		– Sell
-3,260
Closed -$375K – 1537
2019
Q4 		$375K Buy
+3,260
New +$325K 0.02% 1137
2015
Q4 		– Sell
-4,600
Closed -$370K – 637
2015
Q3 		$370K Buy
4,600
+2,100
+84% +$233K 0.03% 492
2015
Q2 		$300K Buy
+2,500
New +$299K 0.03% 795

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Engineers Gate Manager's ALNY Position: Q2 2026 in Review

Engineers Gate Manager increased its Alnylam Pharmaceuticals (ALNY) stake by 3% in Q2 2026, buying an estimated $292K and bringing the position to 33,469 shares worth $10.1M. The position accounts for 0.13% of the portfolio, ranked #172.

Engineers Gate Manager first reported a position in ALNY in Q2 2015 and has held it in 25 quarters since. The position peaked at $20M in Q3 2025. 788 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Engineers Gate Manager held 33,469 shares of Alnylam Pharmaceuticals worth $10.1M as of Q2 2026.
  • Engineers Gate Manager bought 967 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $292K.
  • Alnylam Pharmaceuticals made up 0.13% of Engineers Gate Manager's portfolio in Q2 2026, its #172 holding.
  • Engineers Gate Manager first reported a position in Alnylam Pharmaceuticals in Q2 2015 and has held it in 25 quarters since.
  • Engineers Gate Manager's Alnylam Pharmaceuticals position peaked at $20M in Q3 2025.
  • 788 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.